Detalhe da pesquisa
1.
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU.
Am J Gastroenterol
; 118(6): 1036-1046, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516073
2.
Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.
Gastroenterol Hepatol
; 42(9): 542-547, 2019 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31402179
3.
Characteristics and Progression of Preclinical Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 16(9): 1459-1466, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133254
4.
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients. / Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asociaciones de Enfermedad de Crohn y Colitis Ulcerosa (ACCU) para el manejo de los aspectos psicológicos en la enfermedad inflamatoria intestinal.
Gastroenterol Hepatol
; 41(2): 118-127, 2018 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-29275001
5.
Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain).
Gastroenterology
; 159(2): 781-783, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32330477
6.
Previous exposure to biologics and C-reactive protein are associated with the response to tacrolimus in inflammatory bowel disease.
Rev Esp Enferm Dig
; 108(9): 550-7, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27604685
7.
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry.
J Crohns Colitis
; 17(1): 83-91, 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35913456
8.
Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction.
Sci Rep
; 12(1): 3386, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232999
9.
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Inflamm Bowel Dis
; 28(1): 41-47, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528018
10.
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU.
J Crohns Colitis
; 16(7): 1049-1058, 2022 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35104314
11.
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry.
J Crohns Colitis
; 16(6): 946-953, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864947
12.
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.
Front Med (Lausanne)
; 9: 823900, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35178413
13.
Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
J Clin Gastroenterol
; 45(2): 113-8, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21242747
14.
Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study).
Aliment Pharmacol Ther
; 54(8): 1041-1051, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406676
15.
Early microscopic findings in preclinical inflammatory bowel disease.
Dig Liver Dis
; 52(12): 1467-1472, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601034
16.
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study.
BMJ Open Gastroenterol
; 7(1): e000351, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32337054
17.
Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease.
Aliment Pharmacol Ther
; 51(9): 870-879, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181930
18.
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
United European Gastroenterol J
; 8(9): 1056-1066, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723069
19.
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Inflamm Bowel Dis
; 26(4): 606-616, 2020 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504569
20.
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Am J Gastroenterol
; 104(1): 57-63, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19098850